Pre-market · Regular session opens 9:30 AM ET
Last update: Jun 30, 2026, 3:54 AM ET

Abbott Laboratories (ABT) — What Changed

$92.71-1.41 (-1.50%) vs yesterday's close
Jun 30, 2026 5:03 AM ET·New York Stock Exchange·Pre-market·CEO: Robert Ford·114,000 employees

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of h

🔔Material Change Detected
Market Cap
$161.5B
Sector
Healthcare
Medical - Devices
Next Earnings
Jul 15, 2026
(16 Days)
Relative Volume
0.59x
Below Avg
Risk Level
Low
Price Move
-1.50%
1-Day Change
Below 5D Avg: 0.2%
Volume Confirmation
0.59x
vs 30D Average
Below Avg
Catalyst
Filings
Filings
Abbott Laboratories (ABT) filed its Q1 2026 10-Q on April 29, 2026. The stock…
Peer Context
Outperforming
Top 2 of 6 peers
Company-Specific Move
Signal Quality
Low
Confidence Score
48/100

BestStocks surfaces only meaningful changes—backed by price, volume, catalysts, and peer context—so you can focus on what matters.

1Event Reaction Chart
Price reaction around a key event
ABTAbbott Laboratories$92.71-1.41 (-1.50%)
90.3191.3192.3193.3194.31Price (USD)Jun 23Jun 24Jun 25Jun 26Jun 2992.71
Price Move Up·Jun 25, 2026·+3.04% reaction

1. What Changed Since Last Close

V
Price Move UpLowLow
Jun 26+0.94%0.96x vol

Abbott Laboratories moved +0.94% from $93.24 to $94.12 on 2026-06-26, reaching a new 30-day high. We checked news, earni

V
Price Move UpMediumMedium
Jun 25+3.04%0.98x vol

Abbott Laboratories moved +3.04% from $90.49 to $93.24 on 2026-06-25, reaching a new 30-day high. We checked news, earni

F
New FilingHighHigh
Apr 29

Abbott Laboratories (ABT) filed its Q1 2026 10-Q on April 29, 2026. The stock showed no price movement on the filing dat

F
New FilingHighHigh
Apr 29

Abbott Laboratories (ABT) filed its 10-Q quarterly report on 2026-04-29, with no immediate price movement recorded as of

Showing 4 of 4 events

2. Change Timeline

DateChangePrice Reaction Volume Confidence
Apr 29
FNew Filing
High
Apr 29
FNew Filing
High
Jun 25
VPrice Move Up
+3.04%0.98xMedium
Jun 26
VPrice Move Up
+0.94%0.96xLow
Sort:  

3. Why It Moved

1
Primary Catalyst
Filings
Abbott Laboratories (ABT) filed its Q1 2026 10-Q on April 29, 2026. The stock sh
2
Supporting Evidence
  • Abbott Laboratories moved +3.04% from $90.49 to $93.24 on 2026-06-25,
  • Abbott Laboratories moved +0.94% from $93.24 to $94.12 on 2026-06-26,
3
Nature of Move
Company-Specific Move
ABT outperformed peers by more than expected sector variance — move appears company-specific.

4. Peer / Sector Confirmation

SymbolToday5DRel. Vol
ABT-1.50%0.59xLeader
LLY+1.81%
UNH-1.89%
JNJ+1.51%
PFE+0.39%
ABBV+0.38%
Company-Specific Move. Top 2 of 6 peers. ABT outperformed peers by more than expected sector variance — move appears company-specific.

5. SEC Filing Watch

Apr 29Medium
Quarterly financial results
Apr 27High
Material event — review for impact
Apr 17High
Material event — review for impact
Apr 16High
Material event — review for impact
Mar 23High
Material event — review for impact
Mar 13Low
Annual proxy — exec compensation & governance
Mar 9High
Material event — review for impact
View on SEC EDGAR →Source: filing_snapshots DB · past 120 days

6. Analyst Expectations

Consensus Target
$126.00
Median Target
$123.50
Upside to Target
+35.9%
vs $92.71
Analyst Activity — Last 90 Days
0
Upgrades
14
Maintains
0
Downgrades
Last Directional Actions
↑ Upgrade
Freedom Broker · HoldBuy
Jan 29, 2026
↓ Downgrade
Guggenheim Securities · BuyNeutral
Jan 2, 2020

7. Bull vs Bear Thesis Shift

Bullish Factors
Abbott Laboratories moved +3.04% from $90.49 to $93.24 on 20
Abbott Laboratories moved +0.94% from $93.24 to $94.12 on 20
Bearish Factors
Negative session, down 1.5%
New SEC filing — review for material disclosures
New SEC filing — review for material disclosures
Net Thesis Change vs Yesterday
BearishNeutralBullish
Neutral / Mixed-8 / 100

8. What To Watch Next

DateEventImpact
Jul 16Earnings ReleaseHigh
Jul 29est.10-Q FilingMedium
est. = estimated from prior filing cycle
🔔
9. Set Alerts & Get Notified
Get notified when ABT reports earnings, files an 8-K, receives an analyst upgrade, or sees unusual volume.
Earnings alerts
Filing alerts
Volume spikes
Analyst actions

Educational research tool — not personalized investment advice. Data may be delayed.